{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T09:20:53Z","timestamp":1787908853025,"version":"build-2784847793"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,8,15]],"date-time":"2017-08-15T00:00:00Z","timestamp":1502755200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,8,15]],"date-time":"2017-08-15T00:00:00Z","timestamp":1502755200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    The soil amoebae\n                    <jats:italic>Acanthamoeba<\/jats:italic>\n                    causes\n                    <jats:italic>Acanthamoeba<\/jats:italic>\n                    keratitis, a severe sight-threatening infection of the eye and the almost universally fatal granulomatous amoebic encephalitis. More effective treatments are required. Sterol biosynthesis has been effectively targeted in numerous fungi using azole compounds that inhibit the cytochrome P450 enzyme sterol 14\u03b1-demethylase. Herein, using Gas Chromatography Mass Spectrometry (GCMS), we demonstrate that the major sterol of\n                    <jats:italic>Acanthamoeba castellanii<\/jats:italic>\n                    is ergosterol and identify novel putative precursors and intermediate sterols in its production. Unlike previously reported, we find no evidence of 7-dehydrostigmasterol or any other phytosterol in\n                    <jats:italic>Acanthamoeba<\/jats:italic>\n                    . Of five azoles tested, we demonstrate\u00a0that tioconazole and voriconazole have the greatest overall inhibition for all isolates of\n                    <jats:italic>Acanthamoeba castellanii<\/jats:italic>\n                    and\n                    <jats:italic>Acanthamoeba polyphaga<\/jats:italic>\n                    tested. While miconazole and sulconazole have intermediate activity econazole is least effective. Through GCMS, we demonstrate that voriconazole inhibits 14\u03b1\n                    <jats:bold>-<\/jats:bold>\n                    demethylase as treatment inhibits the production of ergosterol, but results in the accumulation of the lanosterol substrate. These data provide the most complete description of sterol metabolism in\n                    <jats:italic>Acanthamoeba<\/jats:italic>\n                    , provide a putative framework for their further study and validate 14\u03b1\n                    <jats:bold>-<\/jats:bold>\n                    demethylase as the target for azoles in\n                    <jats:italic>Acanthamoeba<\/jats:italic>\n                    .\n                  <\/jats:p>","DOI":"10.1038\/s41598-017-07495-z","type":"journal-article","created":{"date-parts":[[2017,8,9]],"date-time":"2017-08-09T10:22:23Z","timestamp":1502274143000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["Characterisation of sterol biosynthesis and validation of 14\u03b1-demethylase as a drug target in Acanthamoeba"],"prefix":"10.1038","volume":"7","author":[{"given":"Scott","family":"Thomson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0672-9604","authenticated-orcid":false,"given":"Christopher A.","family":"Rice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2420-1117","authenticated-orcid":false,"given":"RuAngelie","family":"Edrada-Ebel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona L.","family":"Henriquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0653-835X","authenticated-orcid":false,"given":"Craig W.","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,8,15]]},"reference":[{"key":"7495_CR1","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1111\/j.1550-7408.2012.00644.x","volume":"59","author":"SM Adl","year":"2012","unstructured":"Adl, S. M. et al. The revised classification of eukaryotes. J Eukaryot Microbiol \n                           59, 429\u2013493, doi:10.1111\/j.1550-7408.2012.00644.x (2012).","journal-title":"J Eukaryot Microbiol"},{"key":"7495_CR2","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1038\/sj.eye.6700563","volume":"17","author":"DV Seal","year":"2003","unstructured":"Seal, D. V. Acanthamoeba keratitis update - incidence, molecular epidemiology and new drugs for treatment. Eye \n                           17, 893\u2013905, doi:10.1038\/sj.eye.6700563 (2003).","journal-title":"Eye"},{"issue":"Pt 5","key":"7495_CR3","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/eye.1994.137","volume":"8","author":"J Hay","year":"1994","unstructured":"Hay, J., Kirkness, C. M., Seal, D. V. & Wright, P. Drug resistance and Acanthamoeba keratitis: the quest for alternative antiprotozoal chemotherapy. Eye (Lond) \n                           8(Pt 5), 555\u2013563, doi:10.1038\/eye.1994.137 (1994).","journal-title":"Eye (Lond)"},{"key":"7495_CR4","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1159\/000334270","volume":"2","author":"G Ferrari","year":"2011","unstructured":"Ferrari, G., Matuska, S. & Rama, P. Double-biguanide therapy for resistant acanthamoeba keratitis. Case Rep Ophthalmol \n                           2, 338\u2013342, doi:10.1159\/000334270 (2011).","journal-title":"Case Rep Ophthalmol"},{"key":"7495_CR5","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S0022-2275(20)42717-8","volume":"9","author":"FR Smith","year":"1968","unstructured":"Smith, F. R. & Korn, E. D. 7-Dehydrostigmasterol and ergosterol: the major sterols of an amoeba. J Lipid Res \n                           9, 405\u2013408 (1968).","journal-title":"J Lipid Res"},{"key":"7495_CR6","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1111\/j.1399-3062.2006.00159.x","volume":"9","author":"R Walia","year":"2007","unstructured":"Walia, R., Montoya, J. G., Visvesvera, G. S., Booton, G. C. & Doyle, R. L. A case of successful treatment of cutaneous Acanthamoeba infection in a lung transplant recipient. Transpl Infect Dis \n                           9, 51\u201354, doi:10.1111\/j.1399-3062.2006.00159.x (2007).","journal-title":"Transpl Infect Dis"},{"key":"7495_CR7","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.ajo.2009.08.004","volume":"149","author":"S Bang","year":"2010","unstructured":"Bang, S., Edell, E., Eghrari, A. O. & Gottsch, J. D. Treatment with voriconazole in 3 eyes with resistant Acanthamoeba keratitis. Am J Ophthalmol \n                           149, 66\u201369, doi:10.1016\/j.ajo.2009.08.004 (2010).","journal-title":"Am J Ophthalmol"},{"key":"7495_CR8","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1097\/ICO.0b013e3181cbfa2c","volume":"29","author":"EY Tu","year":"2010","unstructured":"Tu, E. Y., Joslin, C. E. & Shoff, M. E. Successful treatment of chronic stromal acanthamoeba keratitis with oral voriconazole monotherapy. Cornea \n                           29, 1066\u20131068, doi:10.1097\/ICO.0b013e3181cbfa2c (2010).","journal-title":"Cornea"},{"key":"7495_CR9","doi-asserted-by":"publisher","first-page":"715","DOI":"10.4269\/ajtmh.2012.12-0100","volume":"87","author":"D Webster","year":"2012","unstructured":"Webster, D. et al. Treatment of granulomatous amoebic encephalitis with voriconazole and miltefosine in an immunocompetent soldier. Am J Trop Med Hyg \n                           87, 715\u2013718, doi:10.4269\/ajtmh.2012.12-0100 (2012).","journal-title":"Am J Trop Med Hyg"},{"key":"7495_CR10","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1128\/JCM.43.2.629-634.2005","volume":"43","author":"J McBride","year":"2005","unstructured":"McBride, J., Ingram, P. R., Henriquez, F. L. & Roberts, C. W. Development of colorimetric microtiter plate assay for assessment of antimicrobials against Acanthamoeba. J Clin Microbiol \n                           43, 629\u2013634, doi:10.1128\/JCM.43.2.629-634.2005 (2005).","journal-title":"J Clin Microbiol"},{"key":"7495_CR11","doi-asserted-by":"crossref","unstructured":"McBride J., Mullen A. B., Carter K.C. & Roberts C. W. Differential cytotoxicity of phospholipid analogues to pathogenic Acanthamoeba species and mammalian cells. J Antimicrob Chemother. 60(3), 521\u20135. Epub 2007 Jul 10 (2007).","DOI":"10.1093\/jac\/dkm245"},{"key":"7495_CR12","doi-asserted-by":"crossref","first-page":"3892","DOI":"10.1128\/JCM.38.10.3892-3895.2000","volume":"38","author":"M Seijo Martinez","year":"2000","unstructured":"Seijo Martinez, M. et al. Granulomatous amebic encephalitis in a patient with AIDS: isolation of acanthamoeba sp. Group II from brain tissue and successful treatment with sulfadiazine and fluconazole. J Clin Microbiol \n                           38, 3892\u20133895 (2000).","journal-title":"J Clin Microbiol"},{"key":"7495_CR13","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1128\/AAC.10.2.370","volume":"10","author":"RJ Duma","year":"1976","unstructured":"Duma, R. J. & Finley, R. In vitro susceptibility of pathogenic Naegleria and Acanthamoeba speicies to a variety of therapeutic agents. Antimicrob Agents Chemother \n                           10, 370\u2013376 (1976).","journal-title":"Antimicrob Agents Chemother"},{"key":"7495_CR14","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/j.arcmed.2006.02.007","volume":"37","author":"RN Ondarza","year":"2006","unstructured":"Ondarza, R. N., Iturbe, A. & Hernandez, E. In vitro antiproliferative effects of neuroleptics, antimycotics and antibiotics on the human pathogens Acanthamoeba polyphaga and Naegleria fowleri. Arch Med Res \n                           37, 723\u2013729, doi:10.1016\/j.arcmed.2006.02.007 (2006).","journal-title":"Arch Med Res"},{"key":"7495_CR15","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/0039-128X(88)90051-7","volume":"51","author":"H Mehdi","year":"1988","unstructured":"Mehdi, H., Garg, H. S., Garg, N. K. & Bhakuni, D. S. Sterols of Acanthamoeba culbertsoni strain A-1. Steroids \n                           51, 551\u2013558 (1988).","journal-title":"Steroids"},{"key":"7495_CR16","doi-asserted-by":"publisher","first-page":"R11","DOI":"10.1186\/gb-2013-14-2-r11","volume":"14","author":"M Clarke","year":"2013","unstructured":"Clarke, M. et al. Genome of Acanthamoeba castellanii highlights extensive lateral gene transfer and early evolution of tyrosine kinase signaling. Genome Biol \n                           14, R11, doi:10.1186\/gb-2013-14-2-r11 (2013).","journal-title":"Genome Biol"},{"key":"7495_CR17","doi-asserted-by":"publisher","first-page":"2953","DOI":"10.1128\/IAI.00345-16","volume":"84","author":"A Mattana","year":"2016","unstructured":"Mattana, A. et al. Acanthamoeba castellanii Genotype T4 Stimulates the Production of Interleukin-10 as Well as Proinflammatory Cytokines in THP-1 Cells, Human Peripheral Blood Mononuclear Cells, and Human Monocyte-Derived Macrophages. Infect Immun \n                           84, 2953\u20132962, doi:10.1128\/IAI.00345-16 (2016).","journal-title":"Infect Immun"},{"key":"7495_CR18","doi-asserted-by":"publisher","first-page":"4707","DOI":"10.1128\/AAC.00476-15","volume":"59","author":"DC Lamb","year":"2015","unstructured":"Lamb, D. C. et al. Azole Antifungal Agents To Treat the Human Pathogens Acanthamoeba castellanii and Acanthamoeba polyphaga through Inhibition of Sterol 14alpha-Demethylase (CYP51). Antimicrob Agents Chemother \n                           59, 4707\u20134713, doi:10.1128\/AAC.00476-15 (2015).","journal-title":"Antimicrob Agents Chemother"},{"key":"7495_CR19","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1007\/s00436-013-3705-8","volume":"113","author":"AM Cabello-Vilchez","year":"2014","unstructured":"Cabello-Vilchez, A. M. et al. Voriconazole as a first-line treatment against potentially pathogenic Acanthamoeba strains from Peru. Parasitol Res \n                           113, 755\u2013759, doi:10.1007\/s00436-013-3705-8 (2014).","journal-title":"Parasitol Res"},{"key":"7495_CR20","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1007\/s00417-013-2371-y","volume":"251","author":"CM Martin-Navarro","year":"2013","unstructured":"Martin-Navarro, C. M. et al. Evaluation of the in vitro activity of commercially available moxifloxacin and voriconazole eye-drops against clinical strains of Acanthamoeba. Graefes Arch Clin Exp Ophthalmol \n                           251, 2111\u20132117, doi:10.1007\/s00417-013-2371-y (2013).","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"7495_CR21","doi-asserted-by":"publisher","first-page":"D684","DOI":"10.1093\/nar\/gks1113","volume":"41","author":"C Aurrecoechea","year":"2013","unstructured":"Aurrecoechea, C. et al. EuPathDB: the eukaryotic pathogen database. Nucleic Acids Res \n                           41, D684\u2013691, doi:10.1093\/nar\/gks1113 (2013).","journal-title":"Nucleic Acids Res"},{"key":"7495_CR22","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.protis.2014.12.001","volume":"166","author":"FL Henriquez","year":"2015","unstructured":"Henriquez, F. L. et al. The Acanthamoeba shikimate pathway has a unique molecular arrangement and is essential for aromatic amino acid biosynthesis. Protist \n                           166, 93\u2013105, doi:10.1016\/j.protis.2014.12.001 (2015).","journal-title":"Protist"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-07495-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-07495-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-07495-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T03:44:33Z","timestamp":1671767073000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-07495-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,15]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["7495"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-07495-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,15]]},"assertion":[{"value":"22 February 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"8247"}}